The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Overexpression of Bcl-2 in Transgenic Mice Decreases Apoptosis and Improves Survival in Sepsis
Open accessAbstract
In sepsis there is extensive apoptosis of lymphocytes, which may be beneficial by down-regulating the accompanying inflammation. Alternatively, apoptosis may be detrimental by impairing host defense. We studied whether Bcl-2, a potent antiapoptotic protein, could prevent lymphocyte apoptosis in a clinically relevant model of sepsis. Transgenic mice in which Bcl-2 was overexpressed in T cells had complete protection against sepsis-induced T lymphocyte apoptosis in thymus and spleen. Surprisingly, there was also a decrease in splenic B cell apoptosis in septic Bcl-2 overexpressors compared with septic HeJ and HeOuJ mice. There were marked increases in TNF-α, IL-1β, and IL-10 in thymic tissue in sepsis in the three species of mice, and the increase in TNF-α and IL-10 in HeOuJ mice was greater than that in Bcl-2 mice. Mitotracker, a mitochondrial membrane potential indicator, demonstrated a sepsis-induced loss of membrane potential in T cells in HeJ and HeOuJ mice but not in Bcl-2 mice. Importantly, Bcl-2 overexpressors also had improved survival in sepsis. To investigate the potential impact of loss of lymphocytes on survival in sepsis, Rag-1−/− mice, which are totally deficient in mature T and B cells, were also studied. Rag-1−/− mice had decreased survival compared with immunologically normal mice with sepsis. We conclude that overexpression of Bcl-2 provides protection against cell death in sepsis. Lymphocyte death may be detrimental in sepsis by compromising host defense.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Self-citationRAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,931
The proto-oncogene Bcl-2 and its role in regulating apoptosis
Kroemer, G. (1997) · Nature Medicine · doi:10.1038/nm0697-614 · Cited by 1,739
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Science · doi:10.1126/science.270.5233.96 · Cited by 1,493
Self-citationbcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194
Self-citationSir Isaac Newton, sepsis, SIRS, and CARS
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00010 · Cited by 989
Marzo, I., Brenner, C., Zamzami, N., Susin, S. A., Beutner, G., Brdiczka, D., Rémy, R., Xie, Z.-H., Reed, J. C., & Kroemer, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1261 · Cited by 684
bcl-2 inhibits death of central neural cells induced by multiple agents.
Zhong, L. T., Sarafian, T., Kane, D. J., Charles, A. C., Mah, S. P., Edwards, R. H., & Bredesen, D. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4533 · Cited by 619
ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED
Deitch, E. A. (1998) · Shock · doi:10.1097/00024382-199801000-00001 · Cited by 579
Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins
Zamzami, N., Brenner, C., Marzo, I., Susin, S. A., & Kroemer, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201989 · Cited by 414
Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation
Haimovitz-Friedman, A., Cordon-Cardo, C., Bayoumy, S., Garzotto, M., McLoughlin, M., Gallily, R., Edwards, C. K., Schuchman, E. H., Fuks, Z., & Kolesnick, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1831 · Cited by 408
Bcl-2 and Bax function independently to regulate cell death
Knudson, C. M., & Korsmeyer, S. J. (1997) · Nature Genetics · doi:10.1038/ng0897-358 · Cited by 394
Self-citationHotchkiss, R. S., Swanson, P. E., Cobb, J. P., Jacobson, A., Buchman, T. G., & Karl, I. E. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00015 · Cited by 340
Self-citationCross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.
Linette, G. P., Li, Y., Roth, K., & Korsmeyer, S. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9545 · Cited by 329
Self-citationAyala, A., Herdon, C., Lehman, D., Ayala, C., & Chaudry, I. (1996) · Blood · doi:10.1182/blood.v87.10.4261.bloodjournal87104261 · Cited by 258
Apoptosis: Identification of dying cells
Renvoizé, C., Biola, A., Pallardy, M., & Bréard, J. (1998) · Cell Biology and Toxicology · doi:10.1023/a:1007429904664 · Cited by 239
Sepsis-induced apoptosis of the thymocytes in mice.
Wang, S. D., Huang, K. J., Lin, Y. S., & Lei, H. Y. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5014 · Cited by 232
Neutrophil apoptosis and clearance from neonatal lungs
Grigg, J. M., Silverman, M., Savill, J. S., Sarraf, C., & Haslett, C. (1991) · The Lancet · doi:10.1016/0140-6736(91)91443-x · Cited by 193
bax Deficiency Prevents the Increased Cell Death of Immature Neurons in bcl-x-Deficient Mice
Shindler, K. S., Latham, C. B., & Roth, K. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03112.1997 · Cited by 175
THE INDUCTION OF ACCELERATED THYMIC PROGRAMMED CELL DEATH DURING POLYMICROBIAL SEPSIS
Ayala, A., Herdon, C. D., Lehman, D. L., DeMaso, C. M., Ayala, C. A., & Chaudry, I. H. (1995) · Shock · doi:10.1097/00024382-199504000-00003 · Cited by 131
Search for Sepsis Drugs Goes on Despite Past Failures
Stone, R. (1994) · Science · doi:10.1126/science.8153620 · Cited by 130
Hagberg, L., Briles, D. E., & Edén, C. S. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.4118 · Cited by 80
Clark, B. D., Bedrosian, I., Schindler, R., Cominelli, F., Cannon, J. G., SHAW, A. R., & Dinarello, C. A. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.6.2412 · Cited by 73
DeMeester, S. L., Buchman, T. G., Qiu, Y., Dunnigan, K., Hotchkiss, R. S., Karl, I. E., & Cobb, J. P. (1998) · Shock · doi:10.1097/00024382-199807000-00001 · Cited by 45
Self-citation
Cited by
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Self-citationSepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Self-citationHotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620
Self-citationImmunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70001-x · Cited by 1,442
Self-citationApoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction
Hotchkiss, R. S., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Matuschak, G. M., Buchman, T. G., & Karl, I. E. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00002 · Cited by 1,340
Self-citation
Metadata
- Authors
- Hotchkiss, R. S., Swanson, P. E., Knudson, C. M., Chang, K. C., Cobb, J. P., Osborne, D. F., Zollner, K. M., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-04-01
- Volume
- 162
- Issue
- 7
- Pages
- 4148-4156
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313343369
- Cited by
- 381
- References
- 24
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.